The Race is On: One Month Left to Submit to the Nano Startup Challenge (NSC2) in Cancer Nanomedicine

The National Cancer Institute and Center for Advancing Innovation are sponsoring a challenge to accelerate translation and commercialization of nanomedicines. The Challenge is open to the public and asks entrants to form teams to develop a business plan around cancer nanotechnology inventions. These inventions can originate from an intramural NIH program or can be brought forward by the entering team. Details on the challenge can be found at nano cancer challenge logo

Teams that enter the NSC2 Challenge will be advised and evaluated by a group of experienced researchers, industry leaders, and investors with an ultimate goal to commercialize these inventions. It is expected that the Challenge will help to accelerate and increase the volume of commercialized cancer nanotechnologies, bringing hope and health to millions of families affected by cancer.

The deadline has been extended to March 1st; submissions are due one month from today! A direct link to the Letter of Intent to join the Challenge can be found at: For a complete submission, you will need to:

  1. Choose an Invention (or provide your own Invention)
  2. Fill out the Letter of Intent Form
  3. Complete the CDA and
  4. Submit team member resumes.


For NSC2 Challenge-related questions, please contact:
Rosemarie Truman
CEO, Center for Advancing Innovation